Report #2824374

Received Feb 4, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Unknown
Age: Age unknown
State: FL
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	—

Symptoms (1)

Rash

Symptom narrative

Rash; This non-serious case was reported by a physician via sales rep and described the occurrence of rash in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis. On an unknown date, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced rash (Verbatim: Rash). The outcome of the rash was unknown. The reporter considered the rash to be related to Shingrix. The company considered the rash to be related to Shingrix. Additional Information: GSK Receipt Date: 06-JAN-2025 The reporter reported that patients said they had gotten a rash after the Shingrix vaccine and worry if it was shingles. The reporter wanted to know could this be the case.